波士顿科学

最新新闻

• 评级变动
  Oppenheimer Maintains Boston Scientific(BSX.US) With Buy Rating, Cuts Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• 评级变动
  Argus Research Downgrades Boston Scientific(BSX.US) to Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  BTIG Maintains Boston Scientific(BSX.US) With Buy Rating, Cuts Target Price to $56
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• Barclays Downgrades Boston Scientific(BSX.US) to Hold Rating, Cuts Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 评级变动
  Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $61
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• RBC Capital Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• 评级变动
  Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Boston Scientific (BSX)
  TipRanks · 2026/9/14
• 评级变动
  Wells Fargo Maintains Boston Scientific(BSX.US) With Hold Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• 评级变动
  TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $56
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• J.P. Morgan Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $56
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  Citi Downgrades Boston Scientific(BSX.US) to Hold Rating, Cuts Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  Jefferies Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $60
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• 评级变动
  Jefferies Maintains Boston Scientific(BSX.US) With Buy Rating, Cuts Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $54
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• 评级变动
  Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• Citi Maintains Boston Scientific(BSX.US) With Hold Rating, Cuts Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Wells Fargo Maintains Boston Scientific(BSX.US) With Hold Rating, Cuts Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Artiva Biotherapeutics, Inc. (ARTV)
  TipRanks · 2026/10/2
• 评级变动
  Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Cuts Target Price to $57
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  Citi Maintains Boston Scientific(BSX.US) With Hold Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $55 to $85
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $50 to $70
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $65 to $74
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• 评级变动
  TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $56
  \u5e02\u573a\u8d44\u8baf · 9/5
• 评级变动
  BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $54
  \u5e02\u573a\u8d44\u8baf · 9/8

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。